Russia claims development of Cancer Vaccine, plans free distribution in 2025
The Russian Ministry of Health’s Radiology Medical Research Center has announced the development of a cancer vaccine, which will reportedly be distributed for free starting early 2025.
According to Russia’s TASS news agency, the center has developed an mRNA vaccine against cancer and plans to make it available free of charge to patients.
Andrey Kaprin, Director General of the Radiology Medical Research Center, stated that the vaccine was developed in collaboration with several research centers and will be produced in large quantities by early 2025.
However, Russia has not disclosed specific details about which types of cancer the vaccine targets or its effectiveness.
This announcement comes as the World Health Organization previously warned that global cancer cases are projected to rise by 77% by 2050. The most common types of cancer include breast cancer in women, colorectal cancer, prostate cancer, and stomach cancer.
Scientists have identified various factors contributing to the increasing cancer cases worldwide, including obesity, tobacco use, alcohol consumption, and environmental factors, particularly air pollution.
Research indicates that cancer is spreading more rapidly in low-income countries. Delayed diagnosis and lack of access to healthcare services are the primary reasons for higher cancer mortality rates in these regions.
The development of a cancer vaccine represents a potential breakthrough in global healthcare, but questions remain about its accessibility and effectiveness. If successful, this initiative could significantly reduce cancer-related mortality and improve quality of life for millions.
As cancer cases continue to rise globally, the international community must focus on promoting early diagnosis, increasing access to treatment, and addressing preventable risk factors to combat this growing public health challenge.
The post Russia claims development of Cancer Vaccine, plans free distribution in 2025 appeared first on Khaama Press.